Ergonomics and ME/CFS: Have You Hurt Yourself Without Knowing It?
Having a chronic illness like ME/CFS can make it hard to avoid problems that come from bad ergonomics. Jody Smith has learned some lessons the hard way ...
Discuss the article on the Forums.

Rituxan will be off patent in 2013 in Europe

Discussion in 'Rituximab: News and Research' started by fairlight, Jul 30, 2012.

  1. fairlight

    fairlight

    Messages:
    77
    Likes:
    0
  2. August59

    August59 Daughters High School Graduation

    Messages:
    1,616
    Likes:
    601
    Upstate SC, USA
    Rituximab is also in clinical trials for MS to, I think. Not sure what phase, but if they found enough uses for a generic rituximab it might make it profitable for someone to go after a generic version.
     
  3. shannah

    shannah Senior Member

    Messages:
    906
    Likes:
    274
  4. Sherlock

    Sherlock tart cherry etc. for joints, insomnia

    Messages:
    1,229
    Likes:
    636
    Czechosherlockia, USA
    Unfortunately, AFAIK no one is allowed still to make generic versions of biologic medications, even when off patent in the U.S. as per the FDA. The rationale is that they are too difficult to make properly.


    http://www.businessweek.com/stories...siness-news-stock-market-and-financial-advice

    more here: http://www.merckmanuals.com/home/drugs/trade-name_and_generic_drugs/generic_biologic_drugs.html

    But then, Europe and Mabthera might be different?
     

See more popular forum discussions.

Share This Page